pipette
ENEnglish

Delayed-centrifugation blood collection tube for remote blood biomarker assessment

Y.-R. Lee, A. Raj, O. Lopez, X. Zeng, T. K. Karikari

PreprintUso en el mundo real

En palabras de los autores

Introduction: Plasma phosphorylated tau 217 (p-tau217) and amyloid-{beta} 42 (A{beta}42) are advancing toward clinical use for Alzheimer's disease (AD), but their reliability can be impacted by preanalytical handling. Although alternative collection tubes with distinct stabilization strategies --P100 (protease inhibitor) and HEMAcollect (hemolysis/platelet-activation minimization) --have been developed to stabilize plasma proteins, how well they preserve these markers remains unresolved; we therefore compared both against fresh standard EDTA tubes. Methods: In 40 participants, plasma p-tau217 and A{beta}42 were measured (Lumipulse) in paired fresh EDTA, P100, and HEMAcollect samples after 5-day ambient storage. We assessed concentration change, rank-order preservation (Spearman {rho}), percentage difference, and diagnostic classification under the p-tau217/A{beta}42 ratio and p-tau217 alone. Results: P100 preserved p-tau217 favorably, with high rank-order correlation ({rho}=0.98) and a modest median change (+12.1%), and its classification agreement with fresh EDTA reached 97.5% using p-tau217 alone. HEMAcollect showed greater p-tau217 signal loss (-57.5%). A{beta}42 was reduced in both tubes (-72.8% P100; -95.5% HEMAcollect) with loss of rank order, so neither preserved the p-tau217/A{beta}42 ratio. Discussion: Stability was tube- and analyte-specific, and P100 consistently outperformed HEMAcollect --preserving p-tau217 rank order while HEMAcollect reduced signal across analytes. Although neither tube preserved the A{beta}42-dependent ratio, P100 shows potential for p-tau217-based workflows. Preanalytical stability must be established analyte by analyte before alternative tubes enter clinical AD diagnosis.

Resultado principalEl resumen no menciona limitaciones.

Apareció: martes, 3 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.30.26366958